Alembic Pharmaceuticals Limited, established in 1907, is a leading Indian pharma company with over USD 750 million turnover and presence in 75+ countries. It has strong capabilities in synthetic chemistry, formulation development, and diverse dosage forms. Its advanced R&D focuses on API development, process chemistry, generics, NDDS, and bioequivalence. Manufacturing sites are approved by USFDA, EDQM, and other SRAs